Hm Payson & CO Stoke Therapeutics, Inc. Transaction History

Hm Payson & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$17.19 - $26.1 $1,701 - $2,583	-99 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$18.11 - $30.72 $1,792 - $3,041	99 New	99 $2,000
Q2 2021 Aug 17, 2021	SELL	$30.53 - $41.09 $6,655 - $8,957	-218 Closed	0 $0
Q1 2021 Jun 15, 2021	SELL	$36.08 - $69.81 $2,633 - $5,096	-73 Reduced 25.09%	218 $8,000
Q4 2020 Mar 10, 2021	SELL	$33.62 - $61.93 $2,655 - $4,892	-79 Reduced 21.35%	291 $18,000
Q3 2020 Dec 21, 2020	BUY	$22.23 - $37.48 $8,225 - $13,867	370 New	370 $12,000

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $386M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.